Castle Biosciences's market cap is currently ―. The company's EPS TTM is $-2.152; its P/E ratio is -9.32; Castle Biosciences is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 66.12M	$ 61.49M	$ 50.14M	$ 42.04M	$ 38.34M
Gross Profit	$ 53.70M	$ 50.17M	$ 50.14M	$ 31.86M	$ 28.82M
EBIT	$ -24.25M	$ -6.90M	$ -18.71M	$ -29.16M	$ -22.92M
EBITDA	$ -22.66M	$ -5.29M	$ -16.72M	$ -27.50M	-
Net Income Common Stockholders	$ -2.58M	$ -6.93M	$ -18.78M	$ -29.18M	$ -20.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 243.10M	$ 229.70M	$ 225.50M	$ 232.00M	$ 258.60M
Total Assets	$ 453.34M	$ 436.02M	$ 425.39M	$ 426.89M	$ 447.30M
Total Debt	$ 15.31M	$ 14.53M	$ 14.39M	$ 12.88M	$ 13.31M
Net Debt	$ -227.79M	$ -215.17M	$ -211.11M	$ -219.12M	$ -245.29M
Total Liabilities	$ 62.07M	$ 50.24M	$ 46.63M	$ 41.74M	$ 447.33M
Stockholders Equity	$ 391.27M	$ 385.78M	$ 378.75M	$ 385.15M	$ 399.15M
Cash Flow	-
Free Cash Flow	$ 14.80M	$ 2.56M	$ -7.82M	$ -28.77M	$ -7.30M
Operating Cash Flow	$ 18.59M	$ 5.01M	$ -3.79M	$ -25.44M	$ -5.70M
Investing Cash Flow	$ -7.67M	$ -9.71M	$ -15.39M	$ 16.58M	$ -4.78M
Financing Cash Flow	$ -3.30M	$ 45.00K	$ 226.00K	$ 728.00K	$ -750.00K

Currency in USD

Castle Biosciences Earnings and Revenue History

Income Statement >

Castle Biosciences Debt to Assets

Balance Sheet >

Castle Biosciences Cash Flow

Cash Flow >

Castle Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing